| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |